1Chu SY ,Sennello ST,Bu rnnelt ST et al ,Pbarmacokineticc of clarithromyccin, a new macwrolide, ater single ascending oral doses.An-timicrob Agents chemother.1992,36 : 2447-2453.
2KohnoY, Yoshida H,Suwa T et al : Comparative pharmacokinetics of Clarithromycin(TE-031), a new macrolide antibiotic,and erythromycinin rats, Antimcrob Agents Chemother , 1989,33 (5):751-756.
3Fermamdes PB,Bailer BR,Swanson R,et al,In vitro and in vivo eval-uation of A-56268(TE-031)a mew macrolide, Antimicrob Agents Chemother,1986,30:865-873.
4Hnrody DJ,Swanson RN,Rode RA et al : Enhancement of theinvitroandin vivoactivities of clarithromycin against Haemophilus influen-zae by 14-Hydroxy-clarithromycin,Its major metabolite in humans. Antimicrob Agents chemother ,1990 ,34:1407-1413.
5Kohno Y,Ohta T,Suga T.Autobacteriographic studies of Clarithromycin and Erythromycinin mice, Antimicrob Agents chemoth-er .1990,34:562- 567.
